|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anish Parikh charts the twin rise of biologics and PFS, outlines some of the common challenges associated with filling and dispensing, and discusses how a patient-centric partnership approach can help biopharmaceutical companies shorten the development pathway and ensure a reliable supply of safe, effective medicines for the people who need them.
|
|
|
Jim Huang, PhD, explains how nanosuspensions are an important class of pharmaceutical dosage forms, particularly for pharmaceutical compounds with solubility and bioavailability challenges.
|
|
|
Ajay Damani, VP of Pharmaceutical Technologies Business Unit, Adare, and Maria Flynn, President and CEO, Orbis, discuss how both companies will benefit from the acquisition, future product development, and the challenges of a virtual acquisition.
|
|
|
In part 4 of this 4-part series, PharmaCircle, in collaboration with Drug Development & Delivery, analyzes the pipeline with an emphasis on clinical-stage products for which there is more product-related information.
|
|
|
Contributor Cindy H. Dubin features several leading companies’ innovations in delivery devices as well as how contract parenteral manufacturers are addressing the ever-demanding challenges, issues, and opportunities related to delivering biologics and small molecules.
|
|
|
|
|
|
|
|
|

Headquartered in the heart of the Swiss Alps, Datwyler Sealing Solutions is a leading industrial supplier and key player in global markets for system-critical components in healthcare, automotive, and general industry. The healthcare market segment provides state-of-the-art solutions for parenteral drug and medical device packaging. Datwyler Sealing Solutions is a leading manufacturer and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices are built on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services, including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Click here for more.
|
|
|
|
|
|
 |
|
Evonik recently announced the launch of the RESOMER Precise platform of custom functional polymeric excipients to allow pharmaceutical companies to control…
|
|
 |
|
Junshi Biosciences and Merck recently announced their collaboration on a clinical trial program designed to investigate the efficacy and safety of…
|
|
 |
|
Thermo Fisher Scientific Inc. and CSL Limited recently announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also….
|
|
 |
|
NOVA Thin Film Pharmaceuticals LLC (NTFP) recently announced its formation and the commencement of its soluble thin film operations……
|
|
 |
|
Along with a rapidly expanding global market for innovative lyophilized biologics come increased cost and competitive pressures. Today, it is critical that….
|
|
 |
|
Wondering if investing in a higher purity excipient is really going to pay off? Check out our video web series where we speak to 3 subject matter experts on the benefits of…..
|
|
|
|
|
Upcoming eNewsletter Features:
June 17 – Parenteral Contract Manufacturing
June 24 – Controlled Release
|
|
|
|
|
|
|
|